Aimmune Therapeutics is a biopharmaceutical company focused on developing cures for food allergies. The company's Characterized Oral Desensitization (CODIT) approach is designed to protect patients from life-threatening allergic reactions caused by accidental food allergen exposure. Aimmune currently has one FDA-approved treatment for peanut allergy, and is also developing therapies for other food allergies. The company's goal is to become the global leader in food allergy treatments and improve the lives of people with food allergies.
Aimmune Therapeutics, Inc.'s ticker is AIMT
The company's shares trade on the NASDAQ stock exchange
They are based in Brisbane, California
There are 501-1000 employees working at Aimmune Therapeutics, Inc.
It is https://www.aimmune.com/
Aimmune Therapeutics, Inc. is in the Healthcare sector
Aimmune Therapeutics, Inc. is in the Biotechnology industry
The following five companies are Aimmune Therapeutics, Inc.'s industry peers: